General Information of Drug Inactive Ingredient (DIG) (ID: E00559)

DIG Name
Sodium dihydrogenorthophosphate
Synonyms
Monosodium phosphate; 7558-80-7; Sodium dihydrogenorthophosphate; SODIUM DIHYDROGEN PHOSPHATE; Sodium phosphate monobasic; Sodium acid phosphate; Sodium phosphate, monobasic; Monosodium dihydrogen orthophosphate; sodium dihydrogenphosphate; Acid sodium phosphate; Monosodium monophosphate; Sodium phosphate monobasic anhydrous; Sodium primary phosphate; Monosodium orthophosphate; Sodium dihydrogen orthophosphate; Monosodium dihydrogen phosphate; Monosodium phosphate, anhydrous; Phosphoric acid, monosodium salt; UNII-KH7I04HPUU; Sodium dihydrogen phosphate, anhydrous; NaH2PO4; KH7I04HPUU; sodium;dihydrogen phosphate; CHEBI:37585; Sodiumdihydrogenphosphate-16O4; MFCD00003527; Phosphoric acid, sodium salt (1:1); Sodium phosphate monobasic (anhydrous); SODIUM PHOSPHATE, MONOBASIC ANHYDROUS; Monobasic sodium phosphate; Monosorb XP-4; Phosphoric acid, sodium salt; Primary sodium phosphate; MFCD00146206; Sodium biphosphate anhydrous; Monosodium hydrogen phosphate; Sodium phosphate (NaH2PO4); Sodium orthophosphate, primary; Sodium dihydrogen monophosphate; HSDB 738; Sodium phosphate (Na(H2PO4)); EINECS 231-449-2; Sodium dihydrogen phosphate (1:2:1); Sodium monobasic phosphate (NaH2PO4); Sodium phosphate, monobasic, 98%, extra pure, anhydrous; Sodium dihydrogen phosphate (NaH2PO4); Sodium phosphate, monobasic, 99%, for analysis, anhydrous; Phosphosoda; Buromin; Clicolon; Armite; Sodium phosphate, monobasic, 99%, for biochemistry, anhydrous; Instant calgon; Turrixin ST; HY-Phos; Hemisodium phosphate; ACMC-20ajog; Sodium phosphate glass; sodium dihydrogenphoshate; sodium dihydrogenphospate; sodium dihydrogenphosphat; sodiumdihydrogen phosphate; natriumdihydrogen-phosphate; Sodium phosphate,monobasic; Na.H2PO4; sodium dihydrogen-phosphate; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS; sodium phosphate mono-basic; EC 231-449-2; Monosodium phosphate anhydrous; Sodium biphosphate, anhydrous; Sodium orthophosphate monobasic; Sodium salt of phosphoric acid; INKP 100; INKP-100; DTXSID7035222; INS NO.339(I); Monosodium dihydrogen monophosphate; INS-339(I); Sodium phosphate monobasic solution; Sodium phosphate, monobasic (USP); Anhydrous monobasic sodium phosphate; disodium hydrogen phosphate anhydrous; EINECS 231-558-5; 8871AF; Sodium phosphate monobasic, anhydrous; Phosphoric acid, sodium salt (1:?); AKOS024433265; Sodium phosphate monobasic (anhydrate); DB09449; Sodium phosphate monobasic, AR, >=98%; Sodium phosphate monobasic, LR, >=97%; 89140-32-9; E-339(I); E339; Phosphate, 0.2M buffer solution, pH 4.4; Phosphate, 0.2M buffer solution, pH 6.8; Phosphate, 0.2M buffer solution, pH 7.0; Phosphate, 0.2M buffer solution, pH 7.2; Phosphate, 0.2M buffer solution, pH 7.4; Phosphate, 0.2M buffer solution, pH 7.5; Phosphate, 0.2M buffer solution, pH 7.6; Phosphate, 0.5M buffer solution, pH 6.5; Phosphate, 0.5M buffer solution, pH 7.0; Phosphate, 0.5M buffer solution, pH 7.2; Phosphate, 0.5M buffer solution, pH 7.4; Phosphate, 0.5M buffer solution, pH 8.0; Phosphate, 0.5M buffer solution, pH 8.5; Phosphate, 0.5M buffer solution, pH 9.0; phosphoric acid, monosodium salt, anhydrous; B7779; CS-0021609; FT-0698935; Sodium phosphate monobasic, for HPLC, 99%; D04400; Sodium phosphate monobasic, BioXtra, >=99.0%; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; Q415877; Sodium phosphate monobasic, USP, 98.0-103.0%; Sodium phosphate, 0.2M buffer solution, pH 7.0; Sodium phosphate, 0.2M buffer solution, pH 7.2; Sodium phosphate, 0.2M buffer solution, pH 7.4; Sodium phosphate, 0.2M buffer solution, pH 7.5; Sodium phosphate, 0.2M buffer solution, pH 7.6; Sodium phosphate, 0.2M buffer solution, pH 8.0; Sodium phosphate, 0.2M buffer solution, pH 8.5; Sodium phosphate, 0.2M buffer solution, pH 9.0; Sodium phosphate, 0.2M buffer solution, pH 9.5; Sodium phosphate, 0.5M buffer solution, pH 7.0; Sodium phosphate, 0.5M buffer solution, pH 7.5; Sodium phosphate, 0.5M buffer solution, pH 7.6; Sodium phosphate, 0.5M buffer solution, pH 8.0; Sodium phosphate, 0.5M buffer solution, pH 8.5; Sodium phosphate, 0.5M buffer solution, pH 9.0; Sodium phosphate, 0.5M buffer solution, pH 9.5; 2-Methyl-3-(pyridin-4-ylmethyl)quinazolin-4(3H)-one; Sodium phosphate monobasic, ReagentPlus(R), >=99.0%; Sodium phosphate monobasic, 99.999% trace metals basis; Sodium phosphate monobasic solution, BioUltra, 5 M in H2O; Sodium phosphate monobasic, Vetec(TM) reagent grade, 99%; UNII-3980JIH2SW component AJPJDKMHJJGVTQ-UHFFFAOYSA-M; UNII-SE337SVY37 component AJPJDKMHJJGVTQ-UHFFFAOYSA-M; Sodium phosphate monobasic, SAJ first grade, 98.0-101.0%; Sodium phosphate monobasic, SAJ special grade, 99.0-101.0%; Sodium phosphate monobasic, purum p.a., anhydrous, >=99.0% (T); Sodium phosphate monobasic, meets USP testing specifications, anhydrous; Sodium phosphate monobasic, anhydrous, free-flowing, Redi-Dri(TM), >=99.0%; Sodium phosphate monobasic, BioReagent, for molecular biology, anhydrous, >=98%; Sodium phosphate monobasic, Biotechnology Performance Certified, Cell Culture Tested; Sodium phosphate monobasic Molecular Biology Grade, suitable for cell culture, insect cell culture, and plant cell culture; Sodium phosphate monobasic, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, >=99.0% (titration)
DIG Function
Buffering agent; Complexing agent
Formula
H2NaO4P
Canonical SMILES
OP(=O)(O)[O-].[Na+]
InChI
1S/Na.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+1;/p-1
InChIKey
AJPJDKMHJJGVTQ-UHFFFAOYSA-M
Physicochemical Properties Molecular Weight 119.977 Topological Polar Surface Area 80.6
XlogP N.A. Complexity 61.9
Heavy Atom Count 6 Rotatable Bond Count 0
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 4

Full List of Drug(s) Co-administrated with This DIG

7 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Alcaftadine DM5J1NH Allergic conjunctivitis [9A60.02] Alcaftadine 0.25% solution F23067
Aripiprazole DM3NUMH Bipolar I disorder [] Aripiprazole Lauroxil 662mg/2.4ml extended release suspension F23942
Betamethasone DMAHJEF Acute adrenal insufficiency [] Betamethasone Valerate 0.1% cream F23647
Fenofibrate DMFKXDY Coronary atherosclerosis [] Fenofibrate 160 mg tablet F08001
Fluorometholone DM2HKC4 Chronic obstructive pulmonary disease [CA22] Fluorometholone 0.1% suspension F23171
Interferon Alfa-2b DMWCQP4 Melanoma [2C30] Interferon Alfa-2B 10miu/vial powder For Injection F23785
Sulfacetamide DMZ6VEY Acne vulgaris [ED80] Sulfacetamide 10% solution F23910
------------------
⏷ Show the Full List of 7 Approved Drug(s)
1 Clinical Trial Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
ABT-492 DMJFD2I Bacterial infection [1A00-1C4Z] Delafloxacin 450 mg tablet F05288
------------------